Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study

BACKGROUND AND PURPOSE: Comorbidity in myasthenia gravis (MG) is important for diagnosis, treatment and prognosis. Disease complexity was assessed by examining total drug treatment, immune therapy and comorbidity in a complete national MG cohort. METHODS: All recipients of the MG-specific drug pyrid...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, J B, Owe, J F, Engeland, A, Gilhus, N E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Cme Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238850/
https://www.ncbi.nlm.nih.gov/pubmed/24712740
http://dx.doi.org/10.1111/ene.12439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238850/
https://www.ncbi.nlm.nih.gov/pubmed/24712740
http://dx.doi.org/10.1111/ene.12439

Ejemplares similares